Trial Profile
Phase 1/2 pharmacokinetic trial of AXS-07 in subjects with a history of migraine
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Meloxicam/rizatriptan (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 05 Sep 2019 Results published in the Media Release
- 05 Sep 2019 According to a Axsome Therapeutics media release, the results of this study will be presented at the 19th Congress of the International Headache Society (IHC) in Dublin on September 6, 2019.
- 10 Oct 2018 New trial record